SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-032809
Filing Date
2020-05-28
Accepted
2020-05-28 21:11:38
Documents
1
Period of Report
2020-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4886
  Complete submission text file 0001209191-20-032809.txt   7014
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107 415-993-8570
5AM Opportunities I, L.P. (Reporting) CIK: 0001753000 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38293 | Film No.: 20923797

Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (650) 233-86000
5AM Opportunities I (GP), LLC (Reporting) CIK: 0001790778 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38293 | Film No.: 20923796